Home Mf Research Icici Prudential Pharma Healthcare And Diagnostics Phd Fund Growth
ICICI Prudential Mutual Fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

Equity Equity Sectoral Thematic
Fund House : ICICI Prudential Mutual Fund
Overview
Returns
Portfolio
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI
NAV (as on 2025-06-20)
38.59 0.68%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
-%
Expense Ratio (Direct)
-%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-13 ₹1,000.00 ₹980.19
-1.98 %
Two Week 2025-06-05 ₹1,000.00 ₹995.61
-0.44 %
One Month 2025-05-21 ₹1,000.00 ₹1,008.36
0.84 %
Three Months 2025-03-24 ₹3,000.00 ₹3,075.87
2.53 %
Six Months 2024-12-23 ₹6,000.00 ₹6,202.51
3.38 %
One Year 2024-06-20 ₹12,000.00 ₹12,675.06
5.63 %
Three Year 2022-06-21 ₹36,000.00 ₹54,994.79
52.76 %
Five Year 2020-06-22 ₹60,000.00 ₹106,637.05
77.73 %
Since Inception 2018-07-13 ₹85,000.00 ₹198,755.08
133.83 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology Equity 12.66
Dr. Reddy's Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 9.66
Divi's Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 9.03
Cipla Ltd. Pharmaceuticals & Biotechnology Equity 7.85
Aurobindo Pharma Ltd. Pharmaceuticals & Biotechnology Equity 6.34
Alkem Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 4.12
Zydus Lifesciences Ltd. Pharmaceuticals & Biotechnology Equity 4.01
Lupin Ltd. Pharmaceuticals & Biotechnology Equity 3.98
Gland Pharma Ltd. Pharmaceuticals & Biotechnology Equity 3.95
Syngene International Ltd. Healthcare Services Equity 2.46
Pfizer Ltd. Pharmaceuticals & Biotechnology Equity 2.27
Alembic Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 1.99
Apollo Hospitals Enterprise Ltd. Healthcare Services Equity 1.79
Medplus Health Services Ltd Retailing Equity 1.64
Mankind Pharma Ltd Pharmaceuticals & Biotechnology Equity 1.62
Biocon Ltd. Pharmaceuticals & Biotechnology Equity 1.62
Shilpa Medicare Ltd. Pharmaceuticals & Biotechnology Equity 1.58
Sagility India Ltd It - Services Equity 1.44
Thyrocare Technologies Ltd. Healthcare Services Equity 1.42
Advanced Enzyme Technologies Ltd. Pharmaceuticals & Biotechnology Equity 1.42
Windlas Biotech Ltd. Pharmaceuticals & Biotechnology Equity 1.42
Medi Assist Healthcare Services Ltd Insurance Equity 1.36
Aarti Drugs Ltd. Pharmaceuticals & Biotechnology Equity 1.28
Fine Organic Industries Ltd. Chemicals & Petrochemicals Equity 1.28
Star Health & Allied Insurance Insurance Equity 1.27
Sun Pharma Advanced Research Co. Ltd Pharmaceuticals & Biotechnology Equity 1.16
Yatharth Hospital & Trauma Care Services Pvt Ltd Healthcare Services Equity 1.07
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology Equity 1.01
Glenmark Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 1.00
Aarti Industries Ltd. Chemicals & Petrochemicals Equity 0.98
FDC Ltd. Pharmaceuticals & Biotechnology Equity 0.95
Procter & Gamble Health Ltd. Pharmaceuticals & Biotechnology Equity 0.81
Astrazeneca Pharma India Ltd. Pharmaceuticals & Biotechnology Equity 0.80
Emcure Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 0.72
Senores Pharmaceuticals Ltd Pharmaceuticals & Biotechnology Equity 0.61
Unichem Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 0.26
Laxmi Dental Ltd. Healthcare Equipment & Supplies Equity 0.14
Laxmi Organic Industries Ltd. Chemicals & Petrochemicals Equity 0.01
TREPS - Debt 2.90
Cash Margin - Derivatives - Debt 0.15
Net Current Assets - Debt -0.04
Risk Ratios
Standard Deviation
-
Beta
-
Sharpe Ratio
-
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : -
  • Expense ration regular : -
  • Expense ration direct : -
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹-
  • Type : equity

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?